vs
Orthofix Medical Inc.（OFIX）与RLJ Lodging Trust（RLJ）财务数据对比。点击上方公司名可切换其他公司
RLJ Lodging Trust的季度营收约是Orthofix Medical Inc.的1.5倍（$328.6M vs $219.9M），RLJ Lodging Trust净利率更高（0.1% vs -1.0%，领先1.1%），Orthofix Medical Inc.同比增速更快（2.0% vs -0.4%），RLJ Lodging Trust自由现金流更多（$117.4M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 0.6%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
RLJ集团是美国企业家罗伯特·路易斯·约翰逊创办的资产管理企业。约翰逊在2001年出售自己一手创立的黑人娱乐电视台后，于马里兰州贝塞斯达成立了这家公司。集团业务覆盖酒店不动产投资、私募股权投资、金融服务、资产管理、保险、汽车经销、文体娱乐以及电子彩票 gaming 等多个领域，总部设于贝塞斯达。
OFIX vs RLJ — 直观对比
营收规模更大
RLJ
是对方的1.5倍
$219.9M
营收增速更快
OFIX
高出2.4%
-0.4%
净利率更高
RLJ
高出1.1%
-1.0%
自由现金流更多
RLJ
多$100.6M
$16.8M
两年增速更快
OFIX
近两年复合增速
0.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $328.6M |
| 净利润 | $-2.2M | $430.0K |
| 毛利率 | 71.1% | — |
| 营业利润率 | 0.2% | 0.2% |
| 净利率 | -1.0% | 0.1% |
| 营收同比 | 2.0% | -0.4% |
| 净利润同比 | 92.4% | -92.0% |
| 每股收益（稀释后） | $-0.05 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXRLJ
| Q4 25 | $219.9M | $328.6M | ||
| Q3 25 | $205.6M | $330.0M | ||
| Q2 25 | $203.1M | $363.1M | ||
| Q1 25 | $193.6M | $328.1M | ||
| Q4 24 | $215.7M | $330.0M | ||
| Q3 24 | $196.6M | $345.7M | ||
| Q2 24 | $198.6M | $369.3M | ||
| Q1 24 | $188.6M | $324.4M |
净利润OFIXRLJ
| Q4 25 | $-2.2M | $430.0K | ||
| Q3 25 | $-22.8M | $-3.7M | ||
| Q2 25 | $-14.1M | $28.5M | ||
| Q1 25 | $-53.1M | $3.4M | ||
| Q4 24 | $-29.1M | $5.4M | ||
| Q3 24 | $-27.4M | $20.6M | ||
| Q2 24 | $-33.4M | $37.1M | ||
| Q1 24 | $-36.0M | $4.9M |
毛利率OFIXRLJ
| Q4 25 | 71.1% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 67.8% | — | ||
| Q1 24 | 67.5% | — |
营业利润率OFIXRLJ
| Q4 25 | 0.2% | 0.2% | ||
| Q3 25 | -8.3% | -1.0% | ||
| Q2 25 | -7.9% | 8.0% | ||
| Q1 25 | -25.2% | 1.1% | ||
| Q4 24 | -5.3% | 1.8% | ||
| Q3 24 | -9.6% | 6.1% | ||
| Q2 24 | -12.5% | 10.2% | ||
| Q1 24 | -15.6% | 1.6% |
净利率OFIXRLJ
| Q4 25 | -1.0% | 0.1% | ||
| Q3 25 | -11.1% | -1.1% | ||
| Q2 25 | -6.9% | 7.8% | ||
| Q1 25 | -27.4% | 1.0% | ||
| Q4 24 | -13.5% | 1.6% | ||
| Q3 24 | -13.9% | 6.0% | ||
| Q2 24 | -16.8% | 10.0% | ||
| Q1 24 | -19.1% | 1.5% |
每股收益（稀释后）OFIXRLJ
| Q4 25 | $-0.05 | $-0.05 | ||
| Q3 25 | $-0.57 | $-0.07 | ||
| Q2 25 | $-0.36 | $0.15 | ||
| Q1 25 | $-1.35 | $-0.02 | ||
| Q4 24 | $-0.76 | $-0.01 | ||
| Q3 24 | $-0.71 | $0.09 | ||
| Q2 24 | $-0.88 | $0.20 | ||
| Q1 24 | $-0.95 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $410.2M |
| 总债务越低越好 | — | $2.2B |
| 股东权益账面价值 | $450.0M | $2.2B |
| 总资产 | $850.6M | $4.7B |
| 负债/权益比越低杠杆越低 | — | 1.01× |
8季度趋势，按日历期对齐
现金及短期投资OFIXRLJ
| Q4 25 | $82.0M | $410.2M | ||
| Q3 25 | $62.9M | $374.8M | ||
| Q2 25 | $65.6M | $373.9M | ||
| Q1 25 | $58.0M | $347.5M | ||
| Q4 24 | $83.2M | $409.8M | ||
| Q3 24 | $30.1M | $385.4M | ||
| Q2 24 | $26.4M | $371.1M | ||
| Q1 24 | $27.0M | $350.2M |
总债务OFIXRLJ
| Q4 25 | — | $2.2B | ||
| Q3 25 | $157.2M | $2.2B | ||
| Q2 25 | $157.0M | $2.2B | ||
| Q1 25 | $156.9M | $2.2B | ||
| Q4 24 | $157.0M | $2.2B | ||
| Q3 24 | $118.5M | $2.2B | ||
| Q2 24 | $118.0M | $2.2B | ||
| Q1 24 | $118.2M | $2.2B |
股东权益OFIXRLJ
| Q4 25 | $450.0M | $2.2B | ||
| Q3 25 | $442.5M | $2.2B | ||
| Q2 25 | $458.3M | $2.2B | ||
| Q1 25 | $458.3M | $2.2B | ||
| Q4 24 | $503.1M | $2.3B | ||
| Q3 24 | $525.9M | $2.3B | ||
| Q2 24 | $546.0M | $2.3B | ||
| Q1 24 | $570.3M | $2.3B |
总资产OFIXRLJ
| Q4 25 | $850.6M | $4.7B | ||
| Q3 25 | $832.6M | $4.8B | ||
| Q2 25 | $837.2M | $4.8B | ||
| Q1 25 | $823.1M | $4.8B | ||
| Q4 24 | $893.3M | $4.9B | ||
| Q3 24 | $867.9M | $4.9B | ||
| Q2 24 | $882.0M | $4.9B | ||
| Q1 24 | $906.0M | $4.9B |
负债/权益比OFIXRLJ
| Q4 25 | — | 1.01× | ||
| Q3 25 | 0.36× | 1.01× | ||
| Q2 25 | 0.34× | 1.00× | ||
| Q1 25 | 0.34× | 0.99× | ||
| Q4 24 | 0.31× | 0.97× | ||
| Q3 24 | 0.23× | 0.96× | ||
| Q2 24 | 0.22× | 0.95× | ||
| Q1 24 | 0.21× | 0.96× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $243.8M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $117.4M |
| 自由现金流率自由现金流/营收 | 7.6% | 35.7% |
| 资本支出强度资本支出/营收 | 4.9% | 38.5% |
| 现金转化率经营现金流/净利润 | — | 566.97× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $186.6M |
8季度趋势，按日历期对齐
经营现金流OFIXRLJ
| Q4 25 | $27.7M | $243.8M | ||
| Q3 25 | $12.4M | $63.3M | ||
| Q2 25 | $11.6M | $101.3M | ||
| Q1 25 | $-18.4M | $16.3M | ||
| Q4 24 | $23.7M | $285.4M | ||
| Q3 24 | $11.7M | $80.1M | ||
| Q2 24 | $9.0M | $113.5M | ||
| Q1 24 | $-18.6M | $20.8M |
自由现金流OFIXRLJ
| Q4 25 | $16.8M | $117.4M | ||
| Q3 25 | $2.5M | $33.6M | ||
| Q2 25 | $4.5M | $66.1M | ||
| Q1 25 | $-25.1M | $-30.5M | ||
| Q4 24 | $15.2M | $148.9M | ||
| Q3 24 | $6.3M | $45.4M | ||
| Q2 24 | $-360.0K | $74.9M | ||
| Q1 24 | $-29.1M | $-13.0M |
自由现金流率OFIXRLJ
| Q4 25 | 7.6% | 35.7% | ||
| Q3 25 | 1.2% | 10.2% | ||
| Q2 25 | 2.2% | 18.2% | ||
| Q1 25 | -13.0% | -9.3% | ||
| Q4 24 | 7.0% | 45.1% | ||
| Q3 24 | 3.2% | 13.1% | ||
| Q2 24 | -0.2% | 20.3% | ||
| Q1 24 | -15.4% | -4.0% |
资本支出强度OFIXRLJ
| Q4 25 | 4.9% | 38.5% | ||
| Q3 25 | 4.8% | 9.0% | ||
| Q2 25 | 3.5% | 9.7% | ||
| Q1 25 | 3.5% | 14.3% | ||
| Q4 24 | 4.0% | 41.4% | ||
| Q3 24 | 2.7% | 10.0% | ||
| Q2 24 | 4.7% | 10.4% | ||
| Q1 24 | 5.6% | 10.4% |
现金转化率OFIXRLJ
| Q4 25 | — | 566.97× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.56× | ||
| Q1 25 | — | 4.85× | ||
| Q4 24 | — | 53.09× | ||
| Q3 24 | — | 3.89× | ||
| Q2 24 | — | 3.06× | ||
| Q1 24 | — | 4.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
RLJ
| Occupancy | $262.1M | 80% |
| Food And Beverage | $41.9M | 13% |
| Hotel Other | $24.6M | 7% |
